{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:14:23Z","timestamp":1778822063053,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271839"],"award-info":[{"award-number":["82271839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116600","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:24:45Z","timestamp":1776385485000},"page":"116600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The association of double-negative B cells with atherosclerosis and its severity"],"prefix":"10.1016","volume":"179","author":[{"given":"Ruicong","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10513","key":"10.1016\/j.intimp.2026.116600_bb0005","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.intimp.2026.116600_bb0010","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","author":"Global","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.intimp.2026.116600_bb0015","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/CIRCULATIONAHA.125.075592","article-title":"A crossroads in cardiovascular medicine: Progress and barriers to impact","volume":"152","author":"Regan","year":"2025","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.intimp.2026.116600_bb0020","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/eurheartj\/ehae870","article-title":"Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis","volume":"46","author":"Toval","year":"2025","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.intimp.2026.116600_bb0025","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jacc.2025.07.016","article-title":"Twists and turns on the road to angina relief","volume":"86","author":"Murugiah","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"32","key":"10.1016\/j.intimp.2026.116600_bb0030","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention\u2020","volume":"46","author":"Bay","year":"2025","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.intimp.2026.116600_bb0035","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","article-title":"Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention","volume":"73","author":"Guedeney","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"39","key":"10.1016\/j.intimp.2026.116600_bb0040","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1093\/eurheartj\/ehaf396","article-title":"Atherosclerosis prediction: three pathways, stronger insights","volume":"46","author":"Rocha","year":"2025","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.intimp.2026.116600_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116600_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/art.41485","article-title":"Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus","volume":"73","author":"Saidoune","year":"2021","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.intimp.2026.116600_bb0055","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurheartj\/ehaa995","article-title":"Alarmin-activated b cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms","volume":"42","author":"Kyaw","year":"2021","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.intimp.2026.116600_bb0060","first-page":"2141","article-title":"Immunotherapy for atherosclerosis","volume":"105","author":"Monaco","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2026.116600_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","article-title":"IgD(\u2212)CD27(\u2212) double negative (DN) b cells: origins and functions in health and disease","volume":"255","author":"Beckers","year":"2023","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2026.116600_bb0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.13615","article-title":"Double-negative (DN) b cells: an under-recognized effector memory b cell subset in autoimmunity","volume":"205","author":"Li","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000296","article-title":"Cytoplasmic FOXO1 identifies a novel disease-activity associated b cell phenotype in SLE","volume":"5","author":"Hritzo Ahye","year":"2018","journal-title":"Lupus Sci. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-015-0580-y","article-title":"CD27-IgD- memory b cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis","volume":"17","author":"Mahmood","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2026.116600_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113428","article-title":"Atypical b cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC","volume":"196","author":"Belderbos","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70120","article-title":"The increased secretion of lactate observed in obesity and aging leads to the generation of pathogenic b cells","volume":"56","author":"Romero","year":"2026","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12933-023-02013-0","article-title":"Relationship between TyG index and the degree of coronary artery lesions in patients with h-type hypertension","volume":"23","author":"Xu","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116600_bb0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3748\/wjg.v27.i4.336","article-title":"Clinic-pathological features of metabolic associated fatty liver disease with hepatitis b virus infection","volume":"27","author":"Wang","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116600_bb0105","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","article-title":"Inflammation in atherosclerosis: lessons and therapeutic implications","volume":"58","author":"Libby","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-025-02220-z","article-title":"The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.116600_bb0115","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41569-024-01075-1","article-title":"Atheroimmunology: keeping the immune system in atherosclerosis in check","volume":"21","author":"Monaco","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"13","key":"10.1016\/j.intimp.2026.116600_bb0120","first-page":"2544","article-title":"Humoral immunity in atherosclerosis and myocardial infarction: from b cells to antibodies","volume":"117","author":"Porsch","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.116600_bb0125","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/ATVBAHA.124.319844","article-title":"Therapeutic avenues to modulate B-cell function in patients with cardiovascular disease","volume":"44","author":"O\u2019Brien","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116600_bb0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41569-024-01023-z","article-title":"Targeting immune cell recruitment in atherosclerosis","volume":"21","author":"D\u00f6ring","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116600_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103821","article-title":"The role of double-negative b cells in the pathogenesis of systemic lupus erythematosus","volume":"24","author":"Qiu","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116600_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector b cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116600_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114804","article-title":"Elevated transferrin receptor 1 promoting b-cell autoimmunity in systemic lupus erythematosus","volume":"158","author":"Alim","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.116600_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1241474","article-title":"Double-negative-2 b cells are the major synovial plasma cell precursor in rheumatoid arthritis","volume":"14","author":"Wing","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116600_bb0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cei\/uxad076","article-title":"Aberrant b-cell activation and b-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment","volume":"214","author":"Morales-N\u00fa\u00f1ez","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116600_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13075-024-03264-2","article-title":"Cartilage destruction in early rheumatoid arthritis patients correlates with CD21(\u2212\/low) double-negative b cells","volume":"26","author":"Thorarinsdottir","year":"2024","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.116600_bb0165","article-title":"Unraveling novel subsets of lymphocytes involved in sac expansion in the tertiary lymphoid structure within an abdominal aortic aneurysm","volume":"14","author":"Hosaka","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"11","key":"10.1016\/j.intimp.2026.116600_bb0170","article-title":"CXC chemokine-driven vascular reprogramming: modulating tumor vasculature to boost therapeutic response","volume":"13","author":"Chen","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"issue":"3","key":"10.1016\/j.intimp.2026.116600_bb0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/med.22011","article-title":"CXCR4\/CXCL12 axis: \u201cold\u201d pathway as \u201cnovel\u201d target for anti-inflammatory drug discovery","volume":"44","author":"Lu","year":"2024","journal-title":"Med. Res. Rev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:55:43Z","timestamp":1778820943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926004455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S1567576926004455"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116600","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of double-negative B cells with atherosclerosis and its severity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116600"}}